Does the media favor KIDS or NNOX?

In the previous week, Nano-X Imaging had 22 more articles in the media than OrthoPediatrics. MarketBeat recorded 24 mentions for Nano-X Imaging and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.06 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nano-X Imaging 1 Very Positive mention(s) 2 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer CLPT or NNOX?

In the previous week, Nano-X Imaging had 18 more articles in the media than ClearPoint Neuro. MarketBeat recorded 24 mentions for Nano-X Imaging and 6 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 0.19 beat Nano-X Imaging's score of -0.06 indicating that ClearPoint Neuro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nano-X Imaging 1 Very Positive mention(s) 2 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media refer more to NNOX or SI?

In the previous week, Nano-X Imaging had 20 more articles in the media than Shoulder Innovations. MarketBeat recorded 24 mentions for Nano-X Imaging and 4 mentions for Shoulder Innovations. Nano-X Imaging's average media sentiment score of -0.06 beat Shoulder Innovations' score of -0.53 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 1 Very Positive mention(s) 2 Positive mention(s) 18 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Shoulder Innovations 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Nano-X Imaging (NNOX) Competitors

$1.54 -0.08 (-4.63%)

As of 12:51 PM Eastern

Compare

NNOX vs. KIDS, DCTH, CLPT, SI, and CV

Should you buy Nano-X Imaging stock or one of its competitors? MarketBeat compares Nano-X Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nano-X Imaging include OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), Shoulder Innovations (SI), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Nano-X Imaging compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

In the previous week, Nano-X Imaging had 22 more articles in the media than OrthoPediatrics. MarketBeat recorded 24 mentions for Nano-X Imaging and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.06 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	1 Very Positive mention(s)	2 Positive mention(s)	18 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

OrthoPediatrics has higher revenue and earnings than Nano-X Imaging. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$243.30M	1.96	-$39.65M	-$1.68	N/A
Nano-X Imaging	$13.02M	8.26	-$75.02M	-$1.59	N/A

OrthoPediatrics has a net margin of -16.31% compared to Nano-X Imaging's net margin of -790.87%. OrthoPediatrics' return on equity of -7.01% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

OrthoPediatrics has a beta of 1.03, suggesting that its stock price is 3% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

OrthoPediatrics currently has a consensus price target of $24.44, suggesting a potential upside of 31.63%. Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 223.62%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Summary

OrthoPediatrics beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market.

In the previous week, Nano-X Imaging had 24 more articles in the media than Delcath Systems. MarketBeat recorded 24 mentions for Nano-X Imaging and 0 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.06 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Neutral
Nano-X Imaging	Neutral

Delcath Systems currently has a consensus price target of $22.50, indicating a potential upside of 84.28%. Nano-X Imaging has a consensus price target of $5.00, indicating a potential upside of 223.62%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts plainly believe Nano-X Imaging is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Delcath Systems has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.95	$2.70M	$0.01	1,221.00
Nano-X Imaging	$13.02M	8.26	-$75.02M	-$1.59	N/A

Delcath Systems has a net margin of 0.62% compared to Nano-X Imaging's net margin of -790.87%. Delcath Systems' return on equity of 0.51% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Delcath Systems beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

In the previous week, Nano-X Imaging had 18 more articles in the media than ClearPoint Neuro. MarketBeat recorded 24 mentions for Nano-X Imaging and 6 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 0.19 beat Nano-X Imaging's score of -0.06 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ClearPoint Neuro	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	1 Very Positive mention(s)	2 Positive mention(s)	18 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

ClearPoint Neuro currently has a consensus price target of $23.00, suggesting a potential upside of 23.72%. Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 223.62%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

ClearPoint Neuro has a net margin of -71.57% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

ClearPoint Neuro has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

ClearPoint Neuro has higher revenue and earnings than Nano-X Imaging. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	15.08	-$25.54M	-$1.01	N/A
Nano-X Imaging	$13.02M	8.26	-$75.02M	-$1.59	N/A

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

ClearPoint Neuro beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Shoulder Innovations?

Nano-X Imaging (NASDAQ:NNOX) and Shoulder Innovations (NYSE:SI) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

In the previous week, Nano-X Imaging had 20 more articles in the media than Shoulder Innovations. MarketBeat recorded 24 mentions for Nano-X Imaging and 4 mentions for Shoulder Innovations. Nano-X Imaging's average media sentiment score of -0.06 beat Shoulder Innovations' score of -0.53 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	2 Positive mention(s)	18 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral
Shoulder Innovations	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Shoulder Innovations has a net margin of -81.78% compared to Nano-X Imaging's net margin of -790.87%. Shoulder Innovations' return on equity of -35.11% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
Shoulder Innovations	-81.78%	-35.11%	-20.58%

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 223.62%. Shoulder Innovations has a consensus price target of $21.00, suggesting a potential upside of 12.87%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
Shoulder Innovations	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

21.5% of Nano-X Imaging shares are owned by institutional investors. 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Shoulder Innovations has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	8.26	-$75.02M	-$1.59	N/A
Shoulder Innovations	$53.89M	7.16	-$40.36M	-$166.96	N/A

Summary

Nano-X Imaging and Shoulder Innovations tied by winning 8 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to CapsoVision?

Nano-X Imaging (NASDAQ:NNOX) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

CapsoVision has a net margin of -198.87% compared to Nano-X Imaging's net margin of -790.87%. CapsoVision's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
CapsoVision	-198.87%	N/A	-136.03%

Nano-X Imaging presently has a consensus target price of $5.00, suggesting a potential upside of 223.62%. CapsoVision has a consensus target price of $8.50, suggesting a potential upside of 28.52%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, research analysts plainly believe Nano-X Imaging is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

21.5% of Nano-X Imaging shares are owned by institutional investors. 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

CapsoVision has higher revenue and earnings than Nano-X Imaging. CapsoVision is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	8.26	-$75.02M	-$1.59	N/A
CapsoVision	$13.56M	24.36	-$25.32M	-$2.34	N/A

In the previous week, Nano-X Imaging had 24 more articles in the media than CapsoVision. MarketBeat recorded 24 mentions for Nano-X Imaging and 0 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.00 beat Nano-X Imaging's score of -0.06 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Overall Sentiment
Nano-X Imaging	Neutral
CapsoVision	Neutral

Summary

Nano-X Imaging beats CapsoVision on 8 of the 15 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$108.21M	$4.25B	$6.65B	$12.17B
Dividend Yield	N/A	2.02%	3.17%	5.81%
P/E Ratio	-0.98	41.99	27.93	24.06
Price / Sales	8.26	46.53	394.87	110.93
Price / Cash	N/A	38.90	23.04	37.84
Price / Book	0.77	4.50	5.66	6.54
Net Income	-$75.02M	$31.97M	$205.44M	$336.78M
7 Day Performance	-10.17%	-2.61%	4.58%	0.00%
1 Month Performance	-16.03%	-3.70%	-0.54%	0.99%
1 Year Performance	-68.79%	25.49%	31.63%	32.07%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	3.2635 of 5 stars	$1.55 -4.6%	$5.00 +223.6%	-67.5%	$108.21M	$13.02M	N/A	190	Trending News
KIDS OrthoPediatrics	2.3088 of 5 stars	$18.15 +1.9%	$24.44 +34.7%	-10.5%	$457.71M	$236.35M	N/A	200	Positive News
DCTH Delcath Systems	2.2859 of 5 stars	$11.79 +0.6%	$22.50 +90.8%	-16.9%	$404.59M	$85.23M	1,179.00	60
CLPT ClearPoint Neuro	2.3667 of 5 stars	$13.52 +0.6%	$18.00 +33.1%	+51.5%	$403.06M	$36.97M	N/A	110	Insider Trade Gap Down
SI Shoulder Innovations	2.5411 of 5 stars	$18.05 -3.5%	$21.00 +16.3%	N/A	$387.80M	$47.32M	N/A	61	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, DCTH, CLPT, SI, and CV

How does Nano-X Imaging compare to OrthoPediatrics?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Summary

How does Nano-X Imaging compare to Shoulder Innovations?

Summary

How does Nano-X Imaging compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, DCTH, CLPT, SI, and CV

How does Nano-X Imaging compare to OrthoPediatrics?

Does the media favor KIDS or NNOX?

Do insiders and institutionals hold more shares of KIDS or NNOX?

Which has better valuation & earnings, KIDS or NNOX?

Is KIDS or NNOX more profitable?

Which has more risk and volatility, KIDS or NNOX?

Do analysts rate KIDS or NNOX?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Which has more volatility and risk, DCTH or NNOX?

Does the media prefer DCTH or NNOX?

Do analysts prefer DCTH or NNOX?

Which has higher earnings and valuation, DCTH or NNOX?

Is DCTH or NNOX more profitable?

Do insiders & institutionals believe in DCTH or NNOX?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Does the media prefer CLPT or NNOX?

Do analysts prefer CLPT or NNOX?

Is CLPT or NNOX more profitable?

Which has more volatility and risk, CLPT or NNOX?

Which has preferable valuation & earnings, CLPT or NNOX?

Do institutionals and insiders hold more shares of CLPT or NNOX?

Summary

How does Nano-X Imaging compare to Shoulder Innovations?

Does the media refer more to NNOX or SI?

Is NNOX or SI more profitable?

Do analysts rate NNOX or SI?

Do insiders & institutionals hold more shares of NNOX or SI?

Which has better valuation and earnings, NNOX or SI?

Summary

How does Nano-X Imaging compare to CapsoVision?

Is NNOX or CV more profitable?

Do analysts rate NNOX or CV?

Do insiders and institutionals hold more shares of NNOX or CV?

Which has better earnings & valuation, NNOX or CV?

Does the media prefer NNOX or CV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools